HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,524 | +42.5% | 7,553 | +34.6% | 0.00% | – |
| Q2 2023 | $202,424 | -95.0% | 5,612 | -94.7% | 0.00% | -100.0% |
| Q1 2023 | $4,020,643 | +30.4% | 105,280 | +94.4% | 0.01% | +25.0% |
| Q4 2022 | $3,082,273 | -29.8% | 54,170 | -51.2% | 0.00% | -33.3% |
| Q3 2022 | $4,393,000 | +24.1% | 111,093 | +38.1% | 0.01% | +50.0% |
| Q2 2022 | $3,540,000 | +72.1% | 80,454 | +56.0% | 0.00% | +100.0% |
| Q1 2022 | $2,057,000 | -9.8% | 51,589 | -9.1% | 0.00% | 0.0% |
| Q4 2021 | $2,281,000 | -54.1% | 56,727 | -53.6% | 0.00% | -60.0% |
| Q3 2021 | $4,970,000 | +29.8% | 122,161 | +44.9% | 0.01% | +25.0% |
| Q2 2021 | $3,829,000 | -34.0% | 84,326 | -39.4% | 0.00% | -42.9% |
| Q1 2021 | $5,798,000 | +63.8% | 139,080 | +67.8% | 0.01% | +40.0% |
| Q4 2020 | $3,539,000 | +125.7% | 82,867 | +38.9% | 0.01% | +66.7% |
| Q3 2020 | $1,568,000 | -41.6% | 59,678 | -40.4% | 0.00% | -40.0% |
| Q2 2020 | $2,683,000 | +995.1% | 100,066 | +634.5% | 0.01% | +400.0% |
| Q1 2020 | $245,000 | -63.4% | 13,623 | -68.4% | 0.00% | 0.0% |
| Q3 2019 | $669,000 | -57.4% | 43,140 | -55.8% | 0.00% | -66.7% |
| Q1 2019 | $1,572,000 | +30.5% | 97,659 | +18.6% | 0.00% | 0.0% |
| Q4 2018 | $1,205,000 | +84.0% | 82,339 | +128.5% | 0.00% | +200.0% |
| Q3 2018 | $655,000 | -75.6% | 36,038 | -77.3% | 0.00% | -83.3% |
| Q2 2018 | $2,682,000 | +61.4% | 158,981 | +87.4% | 0.01% | +50.0% |
| Q1 2018 | $1,662,000 | +4.9% | 84,820 | +8.4% | 0.00% | 0.0% |
| Q4 2017 | $1,585,000 | +143.1% | 78,251 | +108.4% | 0.00% | +100.0% |
| Q3 2017 | $652,000 | -28.5% | 37,541 | -47.2% | 0.00% | 0.0% |
| Q2 2017 | $912,000 | +349.3% | 71,106 | +353.8% | 0.00% | +100.0% |
| Q1 2017 | $203,000 | -80.9% | 15,669 | -85.5% | 0.00% | -66.7% |
| Q4 2016 | $1,065,000 | – | 107,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |